Results 181 to 190 of about 198,039 (308)

Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm [PDF]

, 2016
Candace L. Haddox, Niraj Shenoy, Kejal Shah, J. C. Kao, Shikha Jain, Þorvarður R. Hálfdánarson, Eelco F. M. Wijdicks, Moritz Goetz   +7 more
openalex   +1 more source

Global Disproportionality Analysis of Adverse Event Reports on Interstitial Lung Diseases for Cancer‐Targeted Therapies, 1968–2024

Respirology, EarlyView.
ABSTRACT Background and Objectives The increasing complexity of interstitial lung disease (ILD) related to cancer‐targeted monoclonal antibodies (mAbs) has emerged as a significant clinical concern. Thus, this study aimed to investigate reporting signals of four ILD subtypes detected with cancer‐targeted mAbs.
Jinyoung Jeong, Hyunjee Kim, Sooji Lee, Jiyoung Hwang, Lee Smith, Ho Geol Woo, Jaehyeong Cho, Dong Keon Yon   +7 more
wiley   +1 more source

Multiple Cranial Neuropathies After Lenvatinib-Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report. [PDF]

IJU Case Rep
Minagawa H, Kaneko T, Hokkoku K, Miyashima A, Hazuki I, Tenei O, Yagi R, Kishitani K, Takei K, Nakagawa T.   +9 more
europepmc   +1 more source

A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma

, 2017
Zachary Wolner, Ashfaq A. Marghoob, Melissa Pulitzer, Michael A. Postow, Michael A. Marchetti   +4 more
openalex   +2 more sources

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

UroPrecision, EarlyView.
Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing, Zachary Guo, Katherine Wu, Wei Wang, James Jing   +4 more
wiley   +1 more source

A Case of Pathological Complete Response after "Conversion Surgery" for Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma. [PDF]

Surg Case Rep
Shirakawa Y, Yoh T, Ito T, Ogiso S, Ishii T, Fujimoto M, Haga H, Hatano E.   +7 more
europepmc   +1 more source

Multifunctional tumor vaccines carrying thalidomide regulate T cell exhaustion and ferroptosis for immunotherapy strategies

VIEW, EarlyView.
MTV can greatly achieved antigen presenting cell (APCs), and THA will be released from the polyplex core and enhanced antigen presenting, thereby prompting APC maturation and antigen presenting. The membrane antigens on MTV are degraded into small peptides by proteasomes and presented by MHC complexes.
Anmin Huang, Ting Li, Ying Zhou, Sihang Li, Jian Zhang, Yingchao Li, Shijia Wu, Yifan Kong, Zhijie Yu, Jinglin Xia   +9 more
wiley   +1 more source

FIGURE 4 from Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian Cancer

, 2023
Ferdynand J. Kos, Paul Frankel, Mihaela Cristea, Melissa Eng, Raechelle Tinsley, Shannon Dempsey, Nora Ruel, Daphne Stewart, Thanh H. Dellinger, Don J. Diamond   +9 more
openalex   +1 more source

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single‐Center Retrospective Study

The Journal of Dermatology, EarlyView.
ABSTRACT Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for malignant melanoma (MM). However, given variable response rates and potential toxicities, identifying robust biomarkers is crucial. We investigated whether the modified Glasgow Prognostic Score (mGPS) predicts treatment efficacy and toxicity in Asian patients with
Ken Horisaki, Shusuke Yoshikawa, Wataru Omata, Arata Tsutsumida, Yoshio Kiyohara   +4 more
wiley   +1 more source

Case Report: Pembrolizumab associated lichen planus in early stage triple negative breast cancer. [PDF]

Front Oncol
Buyukahisha O, Ozcelik A, Baycelebi D, Cakir A, Cetin B.   +4 more
europepmc   +1 more source